Inventor · disambiguated record
Thomas F. Gajewski
Also filed as: GAJEWSKI THOMAS · GAJEWSKI THOMAS F
16 granted patents·11 pending applications·191 citations·filing 1994–2024
93Inventor score
Top patents by PatentIndex Score
27 records- 0193US7381401B2T cell anergy is reversed by active Ras and regulated by diacylglycerol kinaseUNIV CHICAGO·Filed 2005·Granted Jun 3, 2008·18 cites·4 claims
- 0291US9855302B2Treatment of cancer by manipulation of commensal microfloraUNIV CHICAGO·Filed 2016·Granted Jan 2, 2018·52 cites·29 claims
- 0384US10034939B2Synergistic combination of immunologic inhibitors for the treatment of cancerUNIV CHICAGO·Filed 2013·Granted Jul 31, 2018·6 cites·11 claims
- 0483US10967060B2Synergistic combination of immunologic inhibitors for the treatment of cancerUNIV CHICAGO·Filed 2018·Granted Apr 6, 2021·1 cites·8 claims
- 0581US9944992B2Methods and compositions related to T-cell activityUNIV CHICAGO·Filed 2014·Granted Apr 17, 2018·3 cites·12 claims
- 0681US2024102107A1Methods and compositions related to t-cell activityUNIV CHICAGO·Filed 2023·Application pending·0 cites
- 0780US10815531B2Methods and compositions related to T-cell activityUNIV CHICAGO·Filed 2018·Granted Oct 27, 2020·1 cites·14 claims
- 0876US5591430AIsolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereofLUDWIG INST CANCER RES·Filed 1994·Granted Jan 7, 1997·35 cites·6 claims
- 0975US2025011452A1Dysfunctional antigen-specific cd8+ t cells in the tumor microenvironmentUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 1074US10753938B2Beta-catenin inhibitors in cancer immunotherapyUNIV CHICAGO·Filed 2016·Granted Aug 25, 2020·1 cites·15 claims
- 1171US11802316B2Methods and compositions related to T-cell activityUNIV CHICAGO·Filed 2020·Granted Oct 31, 2023·0 cites·9 claims
- 1270US6682731B1Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 moleculesLUDWIG INST CANCER RES·Filed 2000·Granted Jan 27, 2004·3 cites·2 claims
- 1370US2023416389A1Dysfunctional antigen-specific cd8+ t cells in the tumor microenvironmentUNIV CHICAGO·Filed 2023·Application pending·0 cites
- 1468US11946936B2Beta-catenin inhibitors in cancer immunotherapyUNIV CHICAGO·Filed 2020·Granted Apr 2, 2024·0 cites·21 claims
- 1568US2022296656A1Treatment of cancer by manipulation of commensal microfloraUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 1667US5851523AIsolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereofLUDWIG INST CANCER RES·Filed 1994·Granted Dec 22, 1998·20 cites·7 claims
- 1766US6080399AVaccine adjuvants for immunotherapy of melanomaARCH DEV CORP·Filed 1998·Granted Jun 27, 2000·28 cites·41 claims
- 1866US2021228715A1Synergistic combination of immunologic inhibitors for the treatment of cancerUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 1963US6716422B1Vaccine adjuvants for immunotherapy of melanomaARCH DEV CORP·Filed 1998·Granted Apr 6, 2004·23 cites·43 claims
- 2063US2024327520A1Methods and compositions for pkc-delta inhibition and cancer immunotherapyUNIV CHICAGO·Filed 2022·Application pending·0 cites
- 2158US11566077B2Dysfunctional antigen-specific CD8+ T cells in the tumor microenvironmentUNIV CHICAGO·Filed 2018·Granted Jan 31, 2023·0 cites·13 claims
- 2256US2019183942A1Treatment of cancer by manipulation of commensal microfloraUNIV CHICAGO·Filed 2019·Application pending·0 cites
- 2352US2018015131A1Treatment of cancer by manipulation of commensal microfloraUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 2450US2016287623A1Use of sting agonist as cancer treatmentUNIV CHICAGO·Filed 2014·Application pending·0 cites
- 2547US2005037369A1Panels of molecular targets differentially expressed during CD8+ T cell priming, and methods for therapy and diagnosis utilizing the sameFiled 2003·Application pending·0 cites
- 2645US2018028553A1Use of sting agonist as cancer treatmentUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 2735US11638728B2Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and therapeutic uses thereofUNIV CHICAGO·Filed 2018·Granted May 2, 2023·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Thomas F. Gajewski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →